Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.

Colli Pee Novosanis

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Improving intradermal drug delivery by highly accurate injection of small volumes in the skin

Latest news

Coronavirus Update - Our team is available

In view of the spread of Covid-19 (coronavirus) in our country and across the world, our topmost priority is the health and safety of all our customers and employees. Our team will be available and the best way to reach us at this time is via email: welcome@novosanis.com

Latest blogpost

Vaccines play a critical role in protecting people against disease. HPV vaccination is primarily used for young girls, but is also recommended for boys. This blog explains the potential of HPV vaccination in reducing HPV-related cancers for girls and boys.

Upcoming event

Bio International Convention

BIO International Convention

San Diego
Novosanis will be present at the BIO International Convention as part of the Belgian delegate via Flanders Investment and Trade. The congress takes place in San Diego, from 8 to 11 June. Our CEO (Vanessa Vankerckhoven) and our CTO (Koen Beyers) can be found at the Belgian Pavilion and look forward...